Tags
- 3
- A
- Abnormal
- Adaptation
- Administration
- Advanced
- Advances
- Advancing
- Adverse
- Adverse effect
- Adverse event
- Adverse Events
- Adverse reactions
- Advice
- Agriculture in the United States
- An
- Angiogenesis
- Antihypertensive drug
- Antitarget
- Aorta
- Aortic dissection
- Appropriation
- Approval
- Approved
- Approximately
- Arm
- Around the World
- Artery
- Attack
- AUC
- Australia
- Awaiting
- Based on
- Being
- Benefit
- Benefits
- Biomarker
- Bleeding
- Bleeding diathesis
- Blindness
- Blocking
- Blood
- Blood pressure
- Blood pressure control
- Blood vessel
- Brand
- Breast
- Breastfeeding
- Breast milk
- BSC
- Buisine
- Cambridge
- Cancer
- Cancer center
- Capsule
- Care
- Characteristic
- Chemotherapy
- Chemotherapy-induced acral erythema
- Chief
- Child–Pugh score
- China
- China National
- Class
- Class C
- Clinical
- Clinical significance
- Clinical trial
- Coagulation
- Colorectal cancer
- Combination
- Combination therapy
- Commerce
- Commission
- Commitment
- Complication
- Concentration
- Conducting
- Confusion
- Congenital disorder
- Consent
- Considered
- Consistency
- Consultant
- Contraception
- Contraindication
- Convulsion
- CRC
- Crisis
- Cutaneous condition
- Data
- Death
- Debut novel
- Deep vein
- Deep vein thrombosis
- Delay
- Delayed treatment
- Demonstration
- Deputy
- Deputy Director
- Determined
- Develop
- Development
- Diagnosis
- Diathesis
- Discontinuation
- Disease
- Disorder
- Dissection
- Disturbance
- Division
- Dose
- DR
- Drug
- Early-stage
- Effect
- Efficacy
- Efficacy endpoint
- Efficacy endpoints
- Embolism
- Emergency
- Emergency medicine
- Encephalopathy
- End-of-life
- Endothelium
- Endpoint
- Endpoints
- Enhance
- ESMO
- Estimation
- Europe
- European
- European Commission
- European Union
- Exclusive
- Exposure
- Factor
- Familie
- Families
- Fatal
- FDA
- Fetus
- Five-year survival rate
- Flexibility
- Follows
- Food
- Food and Drug Administration
- Gastrointestinal bleeding
- Gastrointestinal perforation
- Gastrointestinal tract
- Generic
- Generic name
- Global Oncology
- Going Down
- Growth
- Growth factor
- Growth factor receptor
- Headache
- Health
- Health care
- Healthcare personnel
- Hematuria
- Hemoptysis
- Hemorrhage
- Hong Kong
- Hospital
- Hypersensitivity
- Hypertension
- Hypertensive crisis
- If
- Impairment
- Incidence
- Inflammation
- Information Please
- Informed
- Informed consent
- Ingestion
- Ingredient
- Ingredients
- Inhibition
- Inhibitor
- Initiation
- In Japan!
- Insert
- Institution
- Interrupt
- In Treatment
- Investigation
- Ischemia
- Ischemic attack
- Japan
- Japanese
- Kinase
- Kong
- Labour
- Lancet
- Large intestine
- Leader
- Lethargy
- Levels
- License
- Limit
- Limits
- Listed
- Liver
- Liver disease
- Macau
- Mainland
- Mainland China
- Manufacturing
- Market
- Marketing
- Maximum
- MCRC
- Measurement
- Medical
- Medical institution
- Medicine
- Mental
- Mental process
- Metabolism
- Metástasis
- Microangiopathy
- Milk
- Ministry
- Ministry of Health
- Ministry of Health, Labour, and Welfare
- Mortality
- Mortality rate
- Most
- Much
- National Music Publishers Association
- Need
- Neurological impairment
- Neurology
- New
- New Hope
- No
- Nosebleed
- Novel
- Number
- Observation
- Oncology
- Oncology business unit
- Only
- Option
- Options
- Organ
- Over
- Pâ
- Package
- Package insert
- Pass
- Patient
- Pediatrics
- Pediatric use
- Perforation
- Performance
- Persistent
- Personnel
- Pharmaceutical drug
- Pharmacovigilance
- Phase
- Phase 3
- Physician
- Pivotal
- Placebo
- PLU
- Poor
- Poor prognosis
- Portal
- Portal vein
- Portal vein thrombosis
- Positive
- Posterior
- Precautions
- Pregnancy
- Prescription
- Pressure
- Pressure control
- Prevalence
- Primary
- Procedure
- Product
- Profile
- Prognosis
- Progressed
- Progression-free survival
- Promotion
- Protein
- Proteinuria
- Publishing
- Pulmonary embolism
- Reaction
- Receptor
- Recommended
- Recurrence
- Reduction
- Remains
- Reproduction
- Result
- Resumption
- Reversibility
- Risk
- Routine
- Safety
- Safety information
- Screening
- Secondary
- Secondary endpoints
- Selective
- Selectivity
- Severity
- Skeleton
- Skin
- Some
- Special administrative regions of China
- Specific
- Statistical significance
- Statistics
- Steering
- Strategic business unit
- Studie
- Summary
- Summary of Product Characteristics
- Supervision
- Supportive
- Surgery
- Survival
- Survival rate
- Sustain
- Syndrome
- Takayuki Yoshino
- Takeda
- Target
- Targeted
- Targeted therapy
- Teratology
- The european
- The first
- The Initiation
- The Lancet
- The national
- The Promotion
- Therapeutic benefits
- Therapeutic effect
- Therapeutic options
- Therapy
- The Spill Canvas
- The Surgery
- The trial
- The world
- Three
- Thrombosis
- Thrombotic microangiopathy
- Today
- Toxicity
- Tract
- Transient
- Transient ischemic attack
- Treatment of cancer
- Treatment options
- Trial
- Tumor
- Tumor angiogenesis
- Union
- Urgently
- Urinary system
- V
- Variation
- Variations
- Vascular endothelial growth factor
- VEGF receptor
- Vein
- Venous thrombosis
- Vision disorder
- Visual
- Warning
- Welfare
- Who
- Women
- Worldwide
- Wound
- Wound healing
- Yoshino